Zandelisib + Tazemetostat in R/R Follicular Lymphoma

Clinical trial NCT05604417 · WITHDRAWN

Trial details

NCT number

NCT05604417

Sponsor

Jacob Soumerai, MD

Status

WITHDRAWN

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2023-01-01

Primary completion

2024-12-01

Enrollment

0

View on ClinicalTrials.gov